Loading...
Diltiazem — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Diltiazem
2025-Q4
Comprehensive analysis of India’s diltiazem export trade — suppliers, buyers, prices, routes, and every shipment record.
157
Shipments
$1.01M
Trade Value
47
Suppliers
32
Buyers
30
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/diltiazem
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s diltiazem trade — 2025-Q4
KEY TAKEAWAY
Diltiazem 2025-Q4 exports total $1.0M across 30 countries, with EMCURE PHARMACEUTICALS LTD commanding 63.9% market share.
TOTAL SHIPMENTS
157
2025-Q4
EXPORT VALUE
$1.0M
FOB USD
TOTAL QUANTITY
9.7M
units shipped
INDIAN SUPPLIERS
47
unique exporters
GLOBAL BUYERS
32
unique importers
DESTINATIONS
30
countries
MEDIAN UNIT PRICE
$0.998
per unit
TOP-5 SHARE
92.9%
of total USD
BRANDED SHARE
62.4%
98 shipments
DOSAGE FORMS
7
product types
6 KEY FINDINGS
1
EMCURE PHARMACEUTICALS LTD is India's #1 Diltiazem exporter with $647.0K (63.9% market share).→ §5, Indian Supplier Rankings
2
Diltiazem reached 30 countries, with Canada as the top destination ($647.0K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4389) — top 10 suppliers control 97.6% of exports.→ §5, Indian Supplier Rankings
4
84.4% of buyers (27 of 32) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Capsule dominates (55.2%) across 7 dosage forms.→ §7, Price Benchmarks
6
29 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 EMCURE PHARMACEUTICALS LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian diltiazem exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Diltiazem report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial diltiazem trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian diltiazem suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Diltiazem India trade report
Product scope
Diltiazem
All variants merged — branded and generic formulations of diltiazem
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
157
Every commercial diltiazem trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a steady rise: Oct $60.6K, Nov $434.5K, Dec $517.6K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$60.6K
Oct USD
14 shipments
2
$434.5K
Nov USD
+617.4% MoM
3
$517.6K
Dec USD
+19.1% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 617.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $61K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $1.0M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $374K rise in Nov, $83K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $61K | 14 shipments |
| Nov | $435K | 62 shipments |
| Dec | $518K | 81 shipments |
| Q4 Total | $1.0M | 157 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Canada held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: EMCURE PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import diltiazem from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Canada absorbs 63.9% of India’s 2025-Q4 diltiazem trade ($647.0K). Beyond the top 10 destinations, 29 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 29 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much diltiazem India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$159K
15.7% of trade
11 countries · 92 shipments
Europe
$897
0.1% of trade
2 countries · 3 shipments
Americas
$837K
82.7% of trade
7 countries · 44 shipments
Africa
$3K
0.3% of trade
7 countries · 13 shipments
Oceania
$13K
1.2% of trade
3 countries · 5 shipments
Fig 4.1 Canada is the #1 corridor ($647K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian diltiazem it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Canada | $647K | 23 | EMCURE PHARMACEUTICALS LTD | $647K | — | — | — | — |
| 2 | United States | $162K | 9 | ALEMBIC PHARMACEUTICALS LTD | $141K | PIRAMAL PHARMA LTD | $21K | — | — |
| 3 | Sri Lanka | $74K | 7 | INVENTIA HEALTHCARE LTD | $62K | J B CHEMICALS AND PHARMACEUTICALS LTD | $13K | — | — |
| 4 | Nepal | $67K | 16 | TORRENT PHARMACEUTICALS LTD | $58K | MODI-MUNDIPHARMA PVT LTD | $6K | SUN PHARMACEUTICAL INDUSTRIES LTD | $3K |
| 5 | Venezuela | $28K | 5 | LIVEALTH BIOPHARMA PVT LTD | $17K | RONALD PHARMACEUTICALS PVT LTD | $8K | DOSSMEGT PHARMACEUTICALS PVT LTD | $3K |
| 6 | Australia | $12K | 1 | ALEMBIC PHARMACEUTICALS LTD | $12K | — | — | — | — |
| 7 | Iraq | $7K | 7 | HEET HEALTHCARE PVT LTD | $4K | ZEAL PHARMA | $2K | VATS INDUSTRIES PVT LTD | $216 |
| 8 | United Arab Emirates | $6K | 33 | SEATRACK INTERNATIONAL TRADEX PVT LTD | $4K | MEDEX PHARMACEUTICALS | $917 | DROPS PHARMA PVT LTD | $249 |
| 9 | Mauritius | $2K | 1 | TROIKAA PHARMACEUTICALS LTD | $2K | — | — | — | — |
| 10 | Bahrain | $2K | 1 | MILTON LIFECARE PVT LTD | $2K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 15.7% of USD — but Canada is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
63.9%
#1 country share
Canada alone
96.6%
Top 5 share
5 of 30 countries
99.8%
Top 15 share
Long tail of 15 countries = 0.2%
HHI 4445
Destination HHI
Highly concentrated
30
Countries served
Global pharma reach from India
11
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
47 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
EMCURE PHARMACEUTICALS LTD ($647.0K, 63.9% share) and ALEMBIC PHARMACEUTICALS LTD ($152.4K) together control 78.9% of India’s 2025-Q4 diltiazem trade. The top 5 suppliers hold 92.9%. 47 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian diltiazem suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 EMCURE PHARMACEUTICALS LTD leads by $495K over ALEMBIC PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MEDEX PHARMACEUTICALS is #18 by value but #5 by volume.
Fig 5.2 EMCURE PHARMACEUTICALS LTD also leads by shipment count (23) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MEDEX PHARMACEUTICALS moves from #5 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 47 diltiazem suppliers split into strategic segments
KEY TAKEAWAY
12 suppliers (25%) generate 98.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 EMCURE PHARMACEUTICALS LTD and ALEMBIC PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 98.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | INVENTIA HEALTHCARE LTD | 3 | 1 | $62K |
| 2 | EMCURE PHARMACEUTICALS LTD | 2 | 1 | $647K |
| 3 | ALEMBIC PHARMACEUTICALS LTD | 2 | 2 | $152K |
| 4 | MEDEX PHARMACEUTICALS | 2 | 1 | $917 |
| 5 | TORRENT PHARMACEUTICALS LTD | 1 | 1 | $58K |
| 6 | PIRAMAL PHARMA LTD | 1 | 1 | $21K |
| 7 | LIVEALTH BIOPHARMA PVT LTD | 1 | 1 | $17K |
| 8 | J B CHEMICALS AND PHARMACEUTICALS LTD | 1 | 1 | $13K |
| 9 | RONALD PHARMACEUTICALS PVT LTD | 1 | 1 | $8K |
| 10 | MODI-MUNDIPHARMA PVT LTD | 1 | 1 | $6K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the diltiazem manufacturing hubs
KEY TAKEAWAY
Pune and Gujarat together account for $800K of India’s 2025-Q4 diltiazem trade.
Fig 5.5 Pune (2 exporters, $647K) and Gujarat (1 exporters, $152K) are India’s diltiazem capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
92.9%
Top 5 share
5 of 47 suppliers
97.6%
Top 10 share
10 of 47 suppliers
98.4%
Top 25% share
12 suppliers = 98% USD
HHI 4389
Supplier HHI
Concentrated
47
Total suppliers
shipped Diltiazem in 2025-Q4
20+ cities
Indian hubs
Pune and Gujarat lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | ALEMBIC PHARMACEUTICALS LTD | $152K |
| #2 | RUTVA MEDICARE | $555 |
| #3 | BAKER & DAVIS PVT LTD | $223 |
#2
EXPORTER PROFILE #1 OF 3
ALEMBIC PHARMACEUTICALS LTD
Gujarat · India’s #2 diltiazem supplier by USD · 2025-Q4
2025-Q4 USD
$152K
15.0% market share
SHIPMENTS
9
avg $17K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
0%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
United States is the #1 market at $141K (92% of trade), followed by Australia at $12K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $141K | 8 | 92.3% |
| 2 | Australia | $12K | 1 | 7.7% |
MONTHLY TREND
Nov peaked at $140K. Dec was the weakest at $764.
PRODUCT MIX
Tablet dominates at 99% of trade. Capsule (0.5%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| J. KNIPPER & COMPANY | United States | $141K | ⚠ Locked |
| ARROW PHARMACEUTICALS … | Australia | $12K | ⚠ Locked |
#2
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
ALEMBIC PHARMACEUTICALS LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 United States absorbs $141K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#21
2025-Q4 USD
$555
0.1% market share
SHIPMENTS
10
avg $55/ship
COUNTRIES
2
destination markets
BUYERS
1
unique importers
BRANDED
0%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Malaysia is the #1 market at $424 (76% of trade), followed by Zimbabwe at $131. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Malaysia | $424 | 7 | 76.3% |
| 2 | Zimbabwe | $131 | 3 | 23.7% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $547.
PRODUCT MIX
Tablet dominates at 74% of trade. Unknown (24.6%) and Gel are secondary formulations.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Zimbabwe | $555 | N/A |
#21
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
RUTVA MEDICARE — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Malaysia absorbs $424 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#25
EXPORTER PROFILE #3 OF 3
BAKER & DAVIS PVT LTD
Mumbai · India’s #25 diltiazem supplier by USD · 2025-Q4
2025-Q4 USD
$223
0.0% market share
SHIPMENTS
5
avg $45/ship
COUNTRIES
2
destination markets
BUYERS
3
2 single-sourced
BRANDED
80%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Ghana is the #1 market at $190 (85% of trade), followed by United Arab Emirates at $33. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Ghana | $190 | 2 | 85.2% |
| 2 | United Arab Emirates | $33 | 3 | 14.8% |
MONTHLY TREND
Nov peaked at $223. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| FREIGHTER MADE LOGISTI… | Ghana | $190 | ⚠ Locked |
| ARROW TRADING FZE | United Arab Emirates | $22 | ⚠ Locked |
| Undisclosed buyer | United Arab Emirates | $11 | N/A |
#25
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
BAKER & DAVIS PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Ghana absorbs $190 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
32 importers across 30 countries — who is buying Indian diltiazem and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 96.3% of total USD. 84% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian diltiazem. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MARCAN PHARMACEUTICALS INC is the #1 importer at $647K (63.9%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
84%
Single-source
27 buyers rely on exactly 1 Indian supplier
9%
Dual-source
3 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
6%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source diltiazem from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Nepal 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHARMACHEM PVT LTD | TORRENT PHARMACEUTIC… | $58K | $1.052 | Tablet |
| UTL PHARMACY PVT LTD | MODI-MUNDIPHARMA PVT… | $6K | $8.783 | Tablet |
| LIANA TRADE CONCERN PV… | SUN PHARMACEUTICAL I… | $3K | $0.634 | Tablet |
Sri Lanka 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TO HATTON NATIONAL BAN… | INVENTIA HEALTHCARE … | $53K | $1.970 | Tablet |
| GEORGE STEUART HEALTH … | J B CHEMICALS AND PH… | $13K | $7.655 | Tablet |
| TO SAMPATH BANK PLC | INVENTIA HEALTHCARE … | $9K | $1.887 | Capsule |
United Arab Emirates 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BEST INTERNATIONAL FZE | MEDEX PHARMACEUTICALS | $757.437 | $1.165 | Tablet |
| ARROW TRADING FZE | BAKER & DAVIS PVT LTD | $21.870 | $0.109 | Tablet |
| EMIRATES POST GROUP | MOVID IMPEX | $21.581 | $1.660 | Capsule |
United States 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| J. KNIPPER & COMPANY | ALEMBIC PHARMACEUTIC… | $141K | $0.018 | Tablet |
| TEVA PHARMACEUTICALS U… | PIRAMAL PHARMA LTD | $21K | $0.014 | Tablet |
Myanmar 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| JDS CO LTD | SUN PHARMACEUTICAL I… | $705.257 | $4.198 | Tablet |
| IMPERIAL PHOENIX CO LTD | DECINA PHARMA PVT LTD | $406.399 | $0.677 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MARCAN PHARMACEUTICA… | Canada | $647K | $28K | Mid |
| 2 | J. KNIPPER & COMPANY | United States | $141K | $18K | Mid |
| 3 | PHARMACHEM PVT LTD | Nepal | $58K | $6K | Budget |
| 4 | TO HATTON NATIONAL B… | Sri Lanka | $53K | $13K | Budget |
| 5 | TEVA PHARMACEUTICALS… | United States | $21K | $21K | Mid |
| 6 | GEORGE STEUART HEALT… | Sri Lanka | $13K | $13K | Budget |
| 7 | ARROW PHARMACEUTICAL… | Australia | $12K | $12K | Budget |
| 8 | TO SAMPATH BANK PLC | Sri Lanka | $9K | $4K | Budget |
| 9 | UTL PHARMACY PVT LTD | Nepal | $6K | $1K | Budget |
| 10 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $4K | $1K | Budget |
| 11 | LIANA TRADE CONCERN … | Nepal | $3K | $2K | Budget |
| 12 | CASA DE REPRESENTACI… | Venezuela | $3K | $3K | Budget |
| 13 | GULF PHARMACIES W.L.L | Bahrain | $2K | $2K | Budget |
| 14 | MUBARAK HASHIMI LTD | Afghanistan | $1K | $1K | Budget |
| 15 | GLENMARK PHARMACEUTI… | Czech Republic | $895.087 | $895.000 | Budget |
| 16 | BEST INTERNATIONAL FZE | United Arab Emirates | $757.437 | $151.000 | Budget |
| 17 | JDS CO LTD | Myanmar | $705.257 | $705.000 | Budget |
| 18 | IMPERIAL PHOENIX CO … | Myanmar | $406.399 | $406.000 | Budget |
| 19 | EMIRATES POST COMPANY | United Arab Emirates | $263.104 | $15.000 | Budget |
| 20 | FREIGHTER MADE LOGIS… | Ghana | $189.784 | $95.000 | Budget |
| 21 | LLC SHIFOI SONI | Tajikistan | $122.902 | $123.000 | Budget |
| 22 | CARIMED TRADING | Saint Lucia | $72.948 | $36.000 | Budget |
| 23 | CENTRAL POINT PHARMACY | Seychelles | $48.346 | $48.000 | Budget |
| 24 | TREE TOP HEALTH PVT … | Maldives | $44.535 | $6.000 | Budget |
| 25 | LUSAKA PHARMA CHEM S… | Zambia | $40.064 | $20.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 EMCURE PHARMACEUTICALS LTD → MARCAN PHARMACEUTICALS INC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian diltiazem prices vary by supplier, country and dosage form
KEY TAKEAWAY
Diltiazem prices span 94939× ($0.0002 → $21.30). The coefficient of variation is 1.60. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0002 | Lowest observed unit price |
| P5 | $0.0013 | 5th percentile |
| P25 | $0.110 | 25th percentile (Q1) |
| Median | $0.999 | 50th percentile (Q2) |
| P75 | $3.40 | 75th percentile (Q3) |
| P95 | $11.78 | 95th percentile |
| Max | $21.30 | Highest observed unit price |
| Mean | $3.00 | Arithmetic average |
| CV | 160% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 MODI-MUNDIPHARMA PVT LTD prices at $11.32/unit vs market median $0.999.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. ALEMBIC PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. EMCURE PHARMACEUTICALS LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. PIRAMAL PHARMA LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. J B CHEMICALS Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Capsule | 1 | $21.30 | $21.30 | Specialty / small-batch |
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Capsule | 1 | $21.30 | $21.30 | Specialty / small-batch |
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Capsule | 1 | $21.30 | $21.30 | Specialty / small-batch |
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Capsule | 1 | $21.30 | $21.30 | Specialty / small-batch |
| Nov 2025 | LAWRENCE WALTER | United Arab Emirates | Capsule | 1 | $21.30 | $21.30 | Specialty / small-batch |
| Nov 2025 | MODI-MUNDIPHARMA… | Nepal | Tablet | 10 | $204.46 | $20.45 | Specialty / small-batch |
| Nov 2025 | MODI-MUNDIPHARMA… | Nepal | Tablet | 140 | $3K | $20.45 | Specialty / small-batch |
| Dec 2025 | EMCURE PHARMACEU… | Canada | Capsule | 3K | $30K | $11.78 | Specialty / small-batch |
| Dec 2025 | EMCURE PHARMACEU… | Canada | Capsule | 3K | $30K | $11.78 | Specialty / small-batch |
| Dec 2025 | EMCURE PHARMACEU… | Canada | Capsule | 3K | $28K | $9.80 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ALEMBIC PHARMACE… | United States | Capsule | 294K | $314.79 | $0.0011 | |
| Dec 2025 | MC PHARMA DISTRI… | Maldives | Tablet | 180 | $0.267 | $0.0015 | Bulk generic tablet |
| Dec 2025 | NU HOSPITALS PVT… | Maldives | Tablet | 90 | $0.162 | $0.0018 | Bulk generic tablet |
| Dec 2025 | VEA IMPEX (I) PV… | Italy | Injection | 500 | $0.968 | $0.0019 | Sterile formulation premium |
| Dec 2025 | AARK PHARMACEUTI… | Italy | Vial | 330 | $0.940 | $0.0028 | Small sample / trial shipment |
| Nov 2025 | ALEMBIC PHARMACE… | United States | Tablet | 730K | $9K | $0.012 | |
| Nov 2025 | ALEMBIC PHARMACE… | United States | Tablet | 2.2M | $27K | $0.012 | Bulk volume discount |
| Dec 2025 | PIRAMAL PHARMA LTD | United States | Tablet | 1.5M | $21K | $0.014 | Bulk volume discount |
| Dec 2025 | VEA IMPEX (I) PV… | Seychelles | Capsule | 18 | $0.297 | $0.017 | Small sample / trial shipment |
| Nov 2025 | ALEMBIC PHARMACE… | United States | Tablet | 2.0M | $42K | $0.021 | Bulk volume discount |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship diltiazem, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Diltiazem leaves India through 11+ ports. The top 5 (DELHI AIR, NHAVA SHEVA SEA (JNPT), MUMBAI AIR (SAHAR)) handle 98.8% of total USD. AIR moves 75% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $313K — top 11 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 TORONTO is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 75% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$512K
50.6% of USD · 75.2% of ships
SEA
$432K
42.7% of USD · 14.0% of ships
ROAD
$67K
6.6% of USD · 10.2% of ships
ICD
$1K
0.1% of USD · 0.6% of ships
Fig 8.3 The dominant corridor is DELHI AIR → Air → N. America ($307K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Canada is the most concentrated destination (HHI 10000, 1 suppliers). Maldives is the most competitive (HHI 3272).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Canada (HHI 10,000) is the most concentrated — Maldives (HHI 3,272) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MARCAN PHARMACEUTICA… | Canada | EMCURE PHARMACEU… | $647K | 23 | CRITICAL |
| J. KNIPPER & COMPANY | United States | ALEMBIC PHARMACE… | $141K | 8 | HIGH |
| PHARMACHEM PVT LTD | Nepal | TORRENT PHARMACE… | $58K | 9 | MEDIUM |
| TO HATTON NATIONAL B… | Sri Lanka | INVENTIA HEALTHC… | $53K | 4 | MEDIUM |
| TEVA PHARMACEUTICALS… | United States | PIRAMAL PHARMA LTD | $21K | 1 | MEDIUM |
| GEORGE STEUART HEALT… | Sri Lanka | J B CHEMICALS AN… | $13K | 1 | MEDIUM |
| ARROW PHARMACEUTICAL… | Australia | ALEMBIC PHARMACE… | $12K | 1 | MEDIUM |
| TO SAMPATH BANK PLC | Sri Lanka | INVENTIA HEALTHC… | $9K | 2 | MEDIUM |
Conclusion: 27 buyers depend on exactly one Indian supplier, representing $971K in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Canada | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Iraq | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mauritius | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Bahrain | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Czech Republic | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Samoa | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Malaysia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Canada | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Canada lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Canada (1 suppliers) | This Q | HIGH |
| A6 | Enter United States (2 suppliers) | This Q | MED |
| A8 | Build United States distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (EMCURE PHARMACEUTICALS) | This Q | MED |
| A7 | Register for Canada tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Canada | Other | 1 | $647K | +70468.6% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | United States | Other | 2 | $162K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Nepal | Asia | 3 | $67K | +81% | LOW | Growing 81% with only 3 competitors |
| 4 | Sri Lanka | Asia | 2 | $74K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Venezuela | Other | 3 | $28K | -100% | LOW | Low competition (3 suppliers), accessible market |
| 6 | Australia | Other | 1 | $12K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Iraq | Other | 3 | $7K | -20.8% | LOW | Low competition (3 suppliers), accessible market |
| 8 | Mauritius | Africa | 1 | $2K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Zimbabwe | Africa | 1 | $131 | +1437.6% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Bahrain | Other | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Afghanistan | Asia | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Myanmar | Asia | 2 | $1K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Czech Republic | Other | 1 | $895 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Samoa | Other | 1 | $814 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Malaysia | Asia | 2 | $508 | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 157 2025-Q4 Diltiazem shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/diltiazem
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 157 2025-Q4 diltiazem shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian diltiazem shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
157
across all regions
TOTAL USD
$1.01M
2025-Q4 FOB value
UNITS
9.7M
tablets, capsules, etc.
SUPPLIERS
47
Indian exporters
BUYERS
32
global importers
COUNTRIES
30
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $3K (0.3%), spanning 7 countries.
47 Indian suppliers shipped to 32 buyers across 30 countries — average shipment value $6K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
7 countries · 13 shipments · $3K · 8 Indian suppliers · 5 buyers
SHIPMENTS
13
USD
$3K
COUNTRIES
7
SUPPLIERS
8
BUYERS
5
HHI
6,488
concentrated
Top 7 destination countries in Africa
1
Mauritius (79.9%)
$2K
2
Nigeria (6.1%)
$190.00
3
Ghana (6.1%)
$189.78
4
Zimbabwe (4.2%)
$131.29
5
Seychelles (1.6%)
$48.64
6
Zambia (1.3%)
$40.06
7
Uganda (0.7%)
$20.91
Top 8 Indian suppliers into Africa
1
TROIKAA PHARMACEUTICALS LTD
$2K
2
KLV HEALTHCARE PVT LTD
$190.00
3
BAKER & DAVIS PVT LTD
$189.78
4
RUTVA MEDICARE
$131.29
5
NALIINI.R.EXPORT PVT LTD
$48.35
6
MEDICOS LIFESCIENCES
$40.06
7
SOINS IMPEX
$20.91
8
VEA IMPEX (I) PVT LTD
$0.297
Top 3 Africa importers
1
FREIGHTER MADE LOGISTICS LTD · Ghana
$189.78
2
CENTRAL POINT PHARMACY · Seychelles
$48.35
3
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$40.06
Top 5 dosage forms
1
Gel
$2K
2
Tablet
$468.19
3
Unknown
$131.29
4
Ointment
$20.91
5
Capsule
$0.297
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $3K | $843.27 |
| Nov | 4 | $216.11 | $54.03 |
| Dec | 6 | $348.22 | $58.04 |
Shipment register · 13 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — TROIKAA PHARMACEUTICALS LTD · 1 shipments · $2K | |||||||||||
| 1 | Oct 2025 | UNKNOWN BUYER | Mauritius | Gel | 1.0K | NOS | $2.47 | $2K | AHMEDABAD AIR | MAURITIUS | AIR |
| SUPPLIER #2 — KLV HEALTHCARE PVT LTD · 2 shipments · $190.00 | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | Nigeria | Tablet | 500 | NOS | $0.160 | $80.00 | DELHI AIR | LAGOS | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Nigeria | Tablet | 500 | NOS | $0.220 | $110.00 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #3 — BAKER & DAVIS PVT LTD · 2 shipments · $189.78 | |||||||||||
| 4 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 500 | NOS | $0.060 | $29.97 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 5 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 500 | NOS | $0.320 | $159.82 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #4 — RUTVA MEDICARE · 3 shipments · $131.29 | |||||||||||
| 6 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 40 | PCS | $0.200 | $8.02 | AHMEDABAD AIR | HARARE | AIR | |
| 7 | Dec 2025 | UNLISTED BUYER | Zimbabwe | 30 | PCS | $3.08 | $92.46 | AHMEDABAD AIR | HARARE | AIR | |
| 8 | Dec 2025 | UNLISTED BUYER | Zimbabwe | 10 | PCS | $3.08 | $30.82 | AHMEDABAD AIR | HARARE | AIR | |
| SUPPLIER #5 — NALIINI.R.EXPORT PVT LTD · 1 shipments · $48.35 | |||||||||||
| 9 | Oct 2025 | CENTRAL POINT PHARMACY | Seychelles | Tablet | 20 | NOS | $2.42 | $48.35 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #6 — MEDICOS LIFESCIENCES · 2 shipments · $40.06 | |||||||||||
| 10 | Nov 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Tablet | 40 | NOS | $0.135 | $5.42 | AHMEDABAD AIR | LUSAKA | AIR |
| 11 | Dec 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Tablet | 200 | NOS | $0.173 | $34.65 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #7 — SOINS IMPEX · 1 shipments · $20.91 | |||||||||||
| 12 | Nov 2025 | UNLISTED BUYER | Uganda | Ointment | 10 | NOS | $2.09 | $20.91 | AHMEDABAD AIR | KAMPALA | AIR |
| SUPPLIER #8 — VEA IMPEX (I) PVT LTD · 1 shipments · $0.297 | |||||||||||
| 13 | Dec 2025 | UNLISTED BUYER | Seychelles | Capsule | 18 | NOS | $0.017 | $0.297 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
11 countries · 92 shipments · $159K · 27 Indian suppliers · 21 buyers
SHIPMENTS
92
USD
$159K
COUNTRIES
11
SUPPLIERS
27
BUYERS
21
HHI
2,953
concentrated
Top 11 destination countries in Asia
1
Sri Lanka (46.9%)
$74K
2
Nepal (42.3%)
$67K
3
Iraq (4.4%)
$7K
4
United Arab Emirates (3.5%)
$6K
5
Bahrain (1.0%)
$2K
6
Afghanistan (0.7%)
$1K
7
Myanmar (0.7%)
$1K
8
Malaysia (0.3%)
$508.31
9
Oman (0.2%)
$303.57
10
Tajikistan (0.1%)
$122.90
11
Maldives (0.1%)
$91.27
Top 27 Indian suppliers into Asia
1
INVENTIA HEALTHCARE LTD
$62K
2
TORRENT PHARMACEUTICALS LTD
$58K
3
J B CHEMICALS AND PHARMACEUTICALS LTD
$13K
4
MODI-MUNDIPHARMA PVT LTD
$6K
5
HEET HEALTHCARE PVT LTD
$4K
6
SUN PHARMACEUTICAL INDUSTRIES LTD
$4K
7
SEATRACK INTERNATIONAL TRADEX PVT LTD
$4K
8
ZEAL PHARMA
$2K
9
MILTON LIFECARE PVT LTD
$2K
10
KERK
$1K
11
MEDEX PHARMACEUTICALS
$917.16
12
RUTVA MEDICARE
$423.57
13
DECINA PHARMA PVT LTD
$406.40
14
DOSHI MEDICARE PVT LTD
$303.57
15
DROPS PHARMA PVT LTD
$249.48
16
VATS INDUSTRIES PVT LTD
$216.16
17
HUMANKIND PHARMA
$215.04
18
DERRIC WOOD
$147.27
19
M.K.PHARMA
$122.90
20
LAWRENCE WALTER
$115.83
21
MUNANI PHARMACEUTICALS PVT LTD
$84.74
22
NU HOSPITALS PVT LTD
$39.39
23
BAKER & DAVIS PVT LTD
$32.85
24
MC PHARMA DISTRIBUTORS
$30.27
25
MOVID IMPEX
$21.58
26
MEDICARE PHARMA
$14.27
27
VEA IMPEX (I) PVT LTD
$7.34
Top 19 Asia importers
1
PHARMACHEM PVT LTD · Nepal
$58K
2
TO HATTON NATIONAL BANK PLC · Sri Lanka
$53K
3
GEORGE STEUART HEALTH PVT LTD · Sri Lanka
$13K
4
TO SAMPATH BANK PLC · Sri Lanka
$9K
5
UTL PHARMACY PVT LTD · Nepal
$6K
6
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$4K
7
LIANA TRADE CONCERN PVT LTD · Nepal
$3K
8
GULF PHARMACIES W.L.L · Bahrain
$2K
9
MUBARAK HASHIMI LTD · Afghanistan
$1K
10
BEST INTERNATIONAL FZE · United Arab Emirates
$757.44
11
JDS CO LTD · Myanmar
$705.26
12
IMPERIAL PHOENIX CO LTD · Myanmar
$406.40
13
EMIRATES POST COMPANY · United Arab Emirates
$263.10
14
LLC SHIFOI SONI · Tajikistan
$122.90
15
TREE TOP HEALTH PVT LTD · Maldives
$44.54
16
INDIRA GANDHI MEMOROAL HOSPITAL · Maldives
$35.67
17
ARROW TRADING FZE · United Arab Emirates
$21.87
18
EMIRATES POST GROUP · United Arab Emirates
$21.58
19
STATE TRADING ORGANIZATION PLC · Maldives
$3.72
Top 6 dosage forms
1
Tablet
$96K
2
Other
$40K
3
Gel
$14K
4
Capsule
$9K
5
Injection
$263.76
6
Unknown
$10.14
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $20K | $4K |
| Nov | 35 | $78K | $2K |
| Dec | 52 | $61K | $1K |
Shipment register · 92 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INVENTIA HEALTHCARE LTD · 6 shipments · $62K | |||||||||||
| 1 | Nov 2025 | TO HATTON NATIONAL BANK PLC | Sri Lanka | Tablet | 3.5K | NOS | $3.92 | $14K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 2 | Nov 2025 | TO HATTON NATIONAL BANK PLC | Sri Lanka | 3.5K | NOS | $0.0009 | $3.00 | MUMBAI AIR (SAHAR) | COLOMBO | AIR | |
| 3 | Nov 2025 | TO HATTON NATIONAL BANK PLC | Sri Lanka | 9.9K | NOS | $0.0002 | $2.00 | MUMBAI AIR (SAHAR) | COLOMBO | AIR | |
| 4 | Nov 2025 | TO HATTON NATIONAL BANK PLC | Sri Lanka | Other | 10.1K | NOS | $3.92 | $40K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 5 | Dec 2025 | TO SAMPATH BANK PLC | Sri Lanka | Capsule | 2.2K | NOS | $3.93 | $9K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 6 | Dec 2025 | TO SAMPATH BANK PLC | Sri Lanka | Capsule | 2.4K | NOS | $0.0004 | $1.02 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| SUPPLIER #2 — TORRENT PHARMACEUTICALS LTD · 9 shipments · $58K | |||||||||||
| 7 | Oct 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 7.0K | NOS | $1.81 | $13K | RAXAUL | BIRGUNJ | ROAD |
| 8 | Oct 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 5.3K | NOS | $0.731 | $4K | RAXAUL | BIRGUNJ | ROAD |
| 9 | Nov 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 10.0K | NOS | $0.358 | $4K | RAXAUL | Birgunj | ROAD |
| 10 | Nov 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 6.0K | NOS | $0.730 | $4K | RAXAUL | Birgunj | ROAD |
| 11 | Nov 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 4.0K | NOS | $1.81 | $7K | RAXAUL | Birgunj | ROAD |
| 12 | Dec 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 2.0K | NOS | $1.81 | $4K | RAXAUL | BIRGUNJ | ROAD |
| 13 | Dec 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 9.0K | NOS | $1.81 | $16K | RAXAUL | BIRGUNJ | ROAD |
| 14 | Dec 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 6.0K | NOS | $0.359 | $2K | RAXAUL | BIRGUNJ | ROAD |
| 15 | Dec 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 6.0K | NOS | $0.731 | $4K | RAXAUL | BIRGUNJ | ROAD |
| SUPPLIER #3 — J B CHEMICALS AND PHARMACEUTICALS LTD · 1 shipments · $13K | |||||||||||
| 16 | Dec 2025 | GEORGE STEUART HEALTH PVT LTD | Sri Lanka | Tablet | 1.6K | NOS | $7.65 | $13K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #4 — MODI-MUNDIPHARMA PVT LTD · 5 shipments · $6K | |||||||||||
| 17 | Nov 2025 | UTL PHARMACY PVT LTD | Nepal | Tablet | 294 | NOS | $3.51 | $1K | RAXAUL | Birgunj | ROAD |
| 18 | Nov 2025 | UTL PHARMACY PVT LTD | Nepal | Tablet | 35 | NOS | $3.51 | $122.93 | RAXAUL | Birgunj | ROAD |
| 19 | Nov 2025 | UTL PHARMACY PVT LTD | Nepal | Tablet | 150 | NOS | $8.68 | $1K | RAXAUL | Birgunj | ROAD |
| 20 | Nov 2025 | UTL PHARMACY PVT LTD | Nepal | Tablet | 140 | NOS | $20.45 | $3K | RAXAUL | Birgunj | ROAD |
| 21 | Nov 2025 | UTL PHARMACY PVT LTD | Nepal | Tablet | 10 | NOS | $20.45 | $204.46 | RAXAUL | Birgunj | ROAD |
| SUPPLIER #5 — HEET HEALTHCARE PVT LTD · 2 shipments · $4K | |||||||||||
| 22 | Oct 2025 | UNLISTED BUYER | Iraq | Gel | 1.5K | NOS | $2.51 | $4K | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 23 | Dec 2025 | UNLISTED BUYER | Iraq | Gel | 200 | NOS | $2.55 | $509.97 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #6 — SUN PHARMACEUTICAL INDUSTRIES LTD · 3 shipments · $4K | |||||||||||
| 24 | Nov 2025 | JDS CO LTD | Myanmar | Tablet | 168 | NOS | $4.20 | $705.26 | DELHI AIR | YANGON | AIR |
| 25 | Dec 2025 | LIANA TRADE CONCERN PVT LTD | Nepal | Tablet | 3.0K | NOS | $0.777 | $2K | RAXAUL | BIRGUNJ | ROAD |
| 26 | Dec 2025 | LIANA TRADE CONCERN PVT LTD | Nepal | Tablet | 2.5K | NOS | $0.462 | $1K | RAXAUL | BIRGUNJ | ROAD |
| SUPPLIER #7 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 2 shipments · $4K | |||||||||||
| 27 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Gel | 70 | NOS | $2.23 | $156.36 | DELHI AIR | DUBAI | AIR |
| 28 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Gel | 1.6K | NOS | $2.23 | $4K | DELHI AIR | DUBAI | AIR |
| SUPPLIER #8 — ZEAL PHARMA · 4 shipments · $2K | |||||||||||
| 29 | Dec 2025 | UNLISTED BUYER | Iraq | Gel | 300 | NOS | $2.47 | $740.47 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Iraq | Gel | 200 | NOS | $2.47 | $493.65 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 31 | Dec 2025 | UNLISTED BUYER | Iraq | Gel | 300 | NOS | $2.47 | $740.47 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 32 | Dec 2025 | UNLISTED BUYER | Iraq | Gel | 200 | NOS | $2.47 | $493.65 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #9 — MILTON LIFECARE PVT LTD · 1 shipments · $2K | |||||||||||
| 33 | Nov 2025 | GULF PHARMACIES W.L.L | Bahrain | Gel | 400 | NOS | $3.85 | $2K | MUMBAI AIR (SAHAR) | BAHRAIN | AIR |
| SUPPLIER #10 — KERK · 1 shipments · $1K | |||||||||||
| 34 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Gel | 500 | NOS | $2.29 | $1K | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #11 — MEDEX PHARMACEUTICALS · 6 shipments · $917.16 | |||||||||||
| 35 | Nov 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Tablet | 160 | NOS | $0.998 | $159.73 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 36 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 160 | NOS | $0.998 | $159.73 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 37 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Tablet | 40 | NOS | $1.02 | $40.82 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 38 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 50 | NOS | $0.286 | $14.29 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 39 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Tablet | 200 | NOS | $1.36 | $271.30 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 40 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Tablet | 200 | NOS | $1.36 | $271.30 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #12 — RUTVA MEDICARE · 7 shipments · $423.57 | |||||||||||
| 41 | Dec 2025 | UNLISTED BUYER | Malaysia | Tablet | 300 | NOS | $1.38 | $413.30 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| 42 | Dec 2025 | UNLISTED BUYER | Malaysia | 3 | NOS | $1.29 | $3.86 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR | |
| 43 | Dec 2025 | UNLISTED BUYER | Malaysia | 1 | NOS | $1.29 | $1.29 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR | |
| 44 | Dec 2025 | UNLISTED BUYER | Malaysia | Gel | 30 | NOS | $0.034 | $1.03 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| 45 | Dec 2025 | UNLISTED BUYER | Malaysia | Gel | 30 | NOS | $0.034 | $1.03 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| 46 | Dec 2025 | UNLISTED BUYER | Malaysia | Gel | 40 | NOS | $0.034 | $1.37 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| 47 | Dec 2025 | UNLISTED BUYER | Malaysia | Gel | 50 | NOS | $0.034 | $1.71 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #13 — DECINA PHARMA PVT LTD · 1 shipments · $406.40 | |||||||||||
| 48 | Nov 2025 | IMPERIAL PHOENIX CO LTD | Myanmar | Tablet | 600 | NOS | $0.677 | $406.40 | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| SUPPLIER #14 — DOSHI MEDICARE PVT LTD · 1 shipments · $303.57 | |||||||||||
| 49 | Nov 2025 | UNLISTED BUYER | Oman | Gel | 100 | NOS | $3.04 | $303.57 | AHMEDABAD AIR | MUSCAT | AIR |
| SUPPLIER #15 — DROPS PHARMA PVT LTD · 2 shipments · $249.48 | |||||||||||
| 50 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 10 | NOS | $0.198 | $1.98 | COCHIN AIR | DUBAI | AIR |
| 51 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 245 | NOS | $1.01 | $247.50 | COCHIN AIR | DUBAI | AIR |
| SUPPLIER #16 — VATS INDUSTRIES PVT LTD · 1 shipments · $216.16 | |||||||||||
| 52 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 100 | NOS | $2.16 | $216.16 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #17 — HUMANKIND PHARMA · 1 shipments · $215.04 | |||||||||||
| 53 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Gel | 540 | NOS | $0.398 | $215.04 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #18 — DERRIC WOOD · 11 shipments · $147.27 | |||||||||||
| 54 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 15 | PCS | $2.47 | $37.03 | DELHI AIR | DUBAI | AIR |
| 55 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.994 | $11.93 | DELHI AIR | DUBAI | AIR |
| 56 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 9 | PCS | $2.85 | $25.65 | DELHI AIR | DUBAI | AIR |
| 57 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 3 | PCS | $2.86 | $8.59 | DELHI AIR | DUBAI | AIR |
| 58 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 20 | PCS | $1.000 | $19.99 | DELHI AIR | DUBAI | AIR |
| 59 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.998 | $2.00 | DELHI AIR | DUBAI | AIR |
| 60 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.997 | $11.97 | DELHI AIR | DUBAI | AIR |
| 61 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $1.02 | $12.29 | DELHI AIR | DUBAI | AIR |
| 62 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 9 | PCS | $0.028 | $0.249 | DELHI AIR | DUBAI | AIR |
| 63 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 18 | PCS | $0.313 | $5.63 | DELHI AIR | DUBAI | AIR |
| 64 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.996 | $11.95 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #19 — M.K.PHARMA · 1 shipments · $122.90 | |||||||||||
| 65 | Dec 2025 | LLC SHIFOI SONI | Tajikistan | Gel | 50 | PCS | $2.46 | $122.90 | DELHI AIR | DUSHANBE | AIR |
| SUPPLIER #20 — LAWRENCE WALTER · 6 shipments · $115.83 | |||||||||||
| 66 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 1 | PCS | $21.30 | $21.30 | DELHI AIR | DUBAI | AIR |
| 67 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 1 | PCS | $21.30 | $21.30 | DELHI AIR | DUBAI | AIR |
| 68 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 1 | PCS | $21.30 | $21.30 | DELHI AIR | DUBAI | AIR |
| 69 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 1 | PCS | $21.30 | $21.30 | DELHI AIR | DUBAI | AIR |
| 70 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 1 | PCS | $21.30 | $21.30 | DELHI AIR | DUBAI | AIR |
| 71 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 12 | PCS | $0.777 | $9.33 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #21 — MUNANI PHARMACEUTICALS PVT LTD · 1 shipments · $84.74 | |||||||||||
| 72 | Dec 2025 | UNKNOWN BUYER | Malaysia | Gel | 31 | NOS | $2.73 | $84.74 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #22 — NU HOSPITALS PVT LTD · 6 shipments · $39.39 | |||||||||||
| 73 | Oct 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Tablet | 90 | NOS | $0.236 | $21.26 | BANGALORE AIR | MALE | AIR |
| 74 | Dec 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Tablet | 90 | NOS | $0.158 | $14.25 | BANGALORE AIR | MALE | AIR |
| 75 | Dec 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Tablet | 200 | NOS | $0.0002 | $0.045 | BANGALORE AIR | MALE | AIR |
| 76 | Dec 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Tablet | 2.3K | NOS | $0.0006 | $1.29 | BANGALORE AIR | MALE | AIR |
| 77 | Dec 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Tablet | 4.3K | NOS | $0.0006 | $2.39 | BANGALORE AIR | MALE | AIR |
| 78 | Dec 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Tablet | 90 | NOS | $0.0018 | $0.162 | BANGALORE AIR | MALE | AIR |
| SUPPLIER #23 — BAKER & DAVIS PVT LTD · 3 shipments · $32.85 | |||||||||||
| 79 | Nov 2025 | ARROW TRADING FZE | United Arab Emirates | Tablet | 100 | NOS | $0.109 | $10.89 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 80 | Nov 2025 | ARROW TRADING FZE | United Arab Emirates | Tablet | 100 | NOS | $0.110 | $10.98 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 81 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 100 | NOS | $0.110 | $10.98 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #24 — MC PHARMA DISTRIBUTORS · 7 shipments · $30.27 | |||||||||||
| 82 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 120 | PCS | $0.050 | $6.00 | CHENNAI AIR | MALE | AIR |
| 83 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 120 | PCS | $0.050 | $6.00 | CHENNAI AIR | MALE | AIR |
| 84 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 120 | PCS | $0.050 | $6.00 | CHENNAI AIR | MALE | AIR |
| 85 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 120 | PCS | $0.050 | $6.00 | CHENNAI AIR | MALE | AIR |
| 86 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 120 | PCS | $0.050 | $6.00 | CHENNAI AIR | MALE | AIR |
| 87 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 180 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | MALE | AIR |
| 88 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 180 | NOS | $0.0015 | $0.267 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #25 — MOVID IMPEX · 2 shipments · $21.58 | |||||||||||
| 89 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Capsule | 6 | NOS | $0.841 | $5.04 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 90 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Capsule | 7 | NOS | $2.36 | $16.54 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #26 — MEDICARE PHARMA · 1 shipments · $14.27 | |||||||||||
| 91 | Oct 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 180 | PCS | $0.079 | $14.27 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #27 — VEA IMPEX (I) PVT LTD · 1 shipments · $7.34 | |||||||||||
| 92 | Dec 2025 | UNLISTED BUYER | Maldives | Tablet | 90 | NOS | $0.082 | $7.34 | MUMBAI AIR (SAHAR) | MALE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 3 shipments · $896.99 · 3 Indian suppliers · 2 buyers
SHIPMENTS
3
USD
$896.99
COUNTRIES
2
SUPPLIERS
3
BUYERS
2
HHI
9,958
concentrated
Top 2 destination countries in Europe
1
Czech Republic (99.8%)
$895.09
2
Italy (0.2%)
$1.91
Top 3 Indian suppliers into Europe
1
GLENMARK PHARMACEUTICALS LTD
$895.09
2
VEA IMPEX (I) PVT LTD
$0.968
3
AARK PHARMACEUTICALS
$0.940
Top 1 Europe importers
1
GLENMARK PHARMACEUTICALS S.R.O · Czech Republic
$895.09
Top 3 dosage forms
1
Tablet
$895.09
2
Injection
$0.968
3
Vial
$0.940
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 1 | $895.09 | $895.09 |
| Dec | 2 | $1.91 | $0.954 |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — GLENMARK PHARMACEUTICALS LTD · 1 shipments · $895.09 | |||||||||||
| 1 | Nov 2025 | GLENMARK PHARMACEUTICALS S.R.O | Czech Republic | Tablet | 5.8K | NOS | $0.154 | $895.09 | MUMBAI AIR (SAHAR) | FRANKFURT/MAIN INT'L | AIR |
| SUPPLIER #2 — VEA IMPEX (I) PVT LTD · 1 shipments · $0.968 | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | Italy | Injection | 500 | NOS | $0.0019 | $0.968 | MUMBAI AIR (SAHAR) | MILAN | AIR |
| SUPPLIER #3 — AARK PHARMACEUTICALS · 1 shipments · $0.940 | |||||||||||
| 3 | Dec 2025 | UNLISTED BUYER | Italy | Vial | 330 | PCS | $0.0028 | $0.940 | DELHI AIR | MILAN | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 44 shipments · $837K · 11 Indian suppliers · 8 buyers
SHIPMENTS
44
USD
$837K
COUNTRIES
7
SUPPLIERS
11
BUYERS
8
HHI
6,266
concentrated
Top 7 destination countries in Americas
1
Canada (77.3%)
$647K
2
United States (19.3%)
$162K
3
Venezuela (3.4%)
$28K
4
Jamaica (0.0%)
$173.39
5
Saint Lucia (0.0%)
$160.21
6
Trinidad and Tobago (0.0%)
$75.88
7
Cayman Islands (0.0%)
$15.22
Top 11 Indian suppliers into Americas
1
EMCURE PHARMACEUTICALS LTD
$647K
2
ALEMBIC PHARMACEUTICALS LTD
$141K
3
PIRAMAL PHARMA LTD
$21K
4
LIVEALTH BIOPHARMA PVT LTD
$17K
5
RONALD PHARMACEUTICALS PVT LTD
$8K
6
DOSSMEGT PHARMACEUTICALS PVT LTD
$3K
7
DISTINCT IMPEX PVT LTD
$173.39
8
SARA TRADING CORP
$145.39
9
ONCO INDIA INTERNATIONAL
$75.88
10
KALINDI OVERSEAS
$15.22
11
NAMAN GLOBAL IMPEX PVT LTD
$14.81
Top 6 Americas importers
1
MARCAN PHARMACEUTICALS INC · Canada
$647K
2
J. KNIPPER & COMPANY · United States
$141K
3
TEVA PHARMACEUTICALS USA INC · United States
$21K
4
CASA DE REPRESENTACION MARQUEZ Y K · Venezuela
$3K
5
CARIMED TRADING · Saint Lucia
$72.95
6
THE PHARMACIST · Cayman Islands
$15.22
Top 4 dosage forms
1
Capsule
$550K
2
Tablet
$252K
3
Unknown
$35K
4
Gel
$236.50
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $26K | $5K |
| Nov | 18 | $355K | $20K |
| Dec | 21 | $456K | $22K |
Shipment register · 44 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — EMCURE PHARMACEUTICALS LTD · 23 shipments · $647K | |||||||||||
| 1 | Oct 2025 | MARCAN PHARMACEUTICALS INC | Canada | Tablet | 720 | NOS | $0.855 | $615.79 | HYDERABAD AIR | Montreal-Doraval Apt | AIR |
| 2 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 1.6K | NOS | $9.57 | $15K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 3 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 1.4K | NOS | $9.57 | $14K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 4 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 5.6K | NOS | $6.11 | $34K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 5 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | 1.4K | NOS | $8.21 | $12K | MUMBAI AIR (SAHAR) | Toronto | AIR | |
| 6 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | 1.4K | NOS | $8.21 | $12K | MUMBAI AIR (SAHAR) | Toronto | AIR | |
| 7 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | 1.4K | NOS | $8.21 | $12K | MUMBAI AIR (SAHAR) | Toronto | AIR | |
| 8 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 12.5K | NOS | $3.82 | $48K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 9 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 6.0K | NOS | $8.69 | $52K | MUMBAI AIR (SAHAR) | MONTREAL, QC | AIR |
| 10 | Nov 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 1.5K | NOS | $8.92 | $13K | MUMBAI AIR (SAHAR) | MONTREAL, QC | AIR |
| 11 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 8.8K | NOS | $5.39 | $48K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 12 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 3.1K | NOS | $4.40 | $14K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 13 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 879 | NOS | $5.39 | $5K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 14 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 2.6K | NOS | $11.78 | $30K | DELHI AIR | TORONTO | AIR |
| 15 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 2.6K | NOS | $11.78 | $30K | DELHI AIR | TORONTO | AIR |
| 16 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 12.7K | NOS | $7.25 | $92K | DELHI AIR | TORONTO | AIR |
| 17 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 3.7K | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | MONTREAL, QC | SEA |
| 18 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Tablet | 6.4K | NOS | $9.80 | $62K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 19 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 8.3K | NOS | $4.56 | $38K | DELHI AIR | TORONTO | AIR |
| 20 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 2.9K | NOS | $9.80 | $28K | DELHI AIR | TORONTO | AIR |
| 21 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 3.7K | NOS | $5.70 | $21K | DELHI AIR | Montreal-Doraval Apt | AIR |
| 22 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 8.3K | NOS | $4.56 | $38K | DELHI AIR | TORONTO | AIR |
| 23 | Dec 2025 | MARCAN PHARMACEUTICALS INC | Canada | Capsule | 2.9K | NOS | $9.80 | $28K | DELHI AIR | TORONTO | AIR |
| SUPPLIER #2 — ALEMBIC PHARMACEUTICALS LTD · 8 shipments · $141K | |||||||||||
| 24 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 729.6K | TBS | $0.012 | $9K | MUNDRA SEA | Norfolk | SEA |
| 25 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.2M | TBS | $0.012 | $27K | MUNDRA SEA | Norfolk | SEA |
| 26 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 2.0M | TBS | $0.021 | $42K | MUNDRA SEA | Norfolk | SEA |
| 27 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 555.6K | TBS | $0.030 | $17K | MUNDRA SEA | Norfolk | SEA |
| 28 | Nov 2025 | J. KNIPPER & COMPANY | United States | Tablet | 1.3M | TBS | $0.036 | $46K | MUNDRA SEA | Norfolk | SEA |
| 29 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 270.0K | NOS | $0.0010 | $263.24 | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| 30 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 294.0K | NOS | $0.0011 | $314.79 | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| 31 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 326.4K | NOS | $0.0006 | $185.88 | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #3 — PIRAMAL PHARMA LTD · 1 shipments · $21K | |||||||||||
| 32 | Dec 2025 | TEVA PHARMACEUTICALS USA INC | United States | Tablet | 1.5M | NOS | $0.014 | $21K | MUMBAI AIR (SAHAR) | NEW YORK - JOHN F. K | AIR |
| SUPPLIER #4 — LIVEALTH BIOPHARMA PVT LTD · 3 shipments · $17K | |||||||||||
| 33 | Oct 2025 | UNLISTED BUYER | Venezuela | Tablet | 10.0K | NOS | $0.580 | $6K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 34 | Oct 2025 | UNLISTED BUYER | Venezuela | Tablet | 10.0K | NOS | $0.531 | $5K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 35 | Oct 2025 | UNLISTED BUYER | Venezuela | Tablet | 10.0K | NOS | $0.610 | $6K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| SUPPLIER #5 — RONALD PHARMACEUTICALS PVT LTD · 1 shipments · $8K | |||||||||||
| 36 | Oct 2025 | UNLISTED BUYER | Venezuela | Tablet | 16.3K | NOS | $0.501 | $8K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| SUPPLIER #6 — DOSSMEGT PHARMACEUTICALS PVT LTD · 1 shipments · $3K | |||||||||||
| 37 | Nov 2025 | CASA DE REPRESENTACION MARQUEZ Y K | Venezuela | Tablet | 5.3K | NOS | $0.525 | $3K | NHAVA SHEVA SEA (JNPT) | Puerto Cabello | SEA |
| SUPPLIER #7 — DISTINCT IMPEX PVT LTD · 1 shipments · $173.39 | |||||||||||
| 38 | Dec 2025 | UNLISTED BUYER | Jamaica | Tablet | 200 | NOS | $0.867 | $173.39 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| SUPPLIER #8 — SARA TRADING CORP · 3 shipments · $145.39 | |||||||||||
| 39 | Nov 2025 | CARIMED TRADING | Saint Lucia | Gel | 20 | NOS | $3.62 | $72.44 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 40 | Nov 2025 | UNKNOWN BUYER | Saint Lucia | Gel | 20 | NOS | $3.62 | $72.44 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 41 | Dec 2025 | CARIMED TRADING | Saint Lucia | Gel | 10 | NOS | $0.051 | $0.505 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| SUPPLIER #9 — ONCO INDIA INTERNATIONAL · 1 shipments · $75.88 | |||||||||||
| 42 | Dec 2025 | UNLISTED BUYER | Trinidad and Tobago | Gel | 30 | NOS | $2.53 | $75.88 | MUMBAI AIR (SAHAR) | PORT OF SPAIN, PIARC | AIR |
| SUPPLIER #10 — KALINDI OVERSEAS · 1 shipments · $15.22 | |||||||||||
| 43 | Nov 2025 | THE PHARMACIST | Cayman Islands | Gel | 5 | NOS | $3.04 | $15.22 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #11 — NAMAN GLOBAL IMPEX PVT LTD · 1 shipments · $14.81 | |||||||||||
| 44 | Dec 2025 | UNKNOWN BUYER | Saint Lucia | Capsule | 10 | NOS | $1.48 | $14.81 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
3 countries · 5 shipments · $13K · 3 Indian suppliers · 3 buyers
SHIPMENTS
5
USD
$13K
COUNTRIES
3
SUPPLIERS
3
BUYERS
3
HHI
8,768
concentrated
Top 3 destination countries in Oceania
1
Australia (93.4%)
$12K
2
Samoa (6.5%)
$813.61
3
Papua New Guinea (0.1%)
$11.55
Top 3 Indian suppliers into Oceania
1
ALEMBIC PHARMACEUTICALS LTD
$12K
2
ELITE MEDICOS
$813.61
3
BIOLOG PHARMA PVT LTD
$11.55
Top 1 Oceania importers
1
ARROW PHARMACEUTICALS LTD · Australia
$12K
Top 1 dosage forms
1
Tablet
$13K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $12K | $12K |
| Nov | 4 | $825.16 | $206.29 |
| Dec | 0 | $0.0000 | — |
Shipment register · 5 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ALEMBIC PHARMACEUTICALS LTD · 1 shipments · $12K | |||||||||||
| 1 | Oct 2025 | ARROW PHARMACEUTICALS LTD | Australia | Tablet | 283.9K | TBS | $0.041 | $12K | MUNDRA SEA | Sydney | SEA |
| SUPPLIER #2 — ELITE MEDICOS · 3 shipments · $813.61 | |||||||||||
| 2 | Nov 2025 | UNKNOWN BUYER | Samoa | Tablet | 3.0K | PCS | $0.100 | $295.49 | DELHI AIR | APIA | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Samoa | Tablet | 4.7K | PCS | $0.070 | $331.23 | DELHI AIR | APIA | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Samoa | Tablet | 1.4K | PCS | $0.130 | $186.88 | DELHI AIR | APIA | AIR |
| SUPPLIER #3 — BIOLOG PHARMA PVT LTD · 1 shipments · $11.55 | |||||||||||
| 5 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 110 | NOS | $0.105 | $11.55 | AHMEDABAD AIR | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 47 Indian diltiazem exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped diltiazem in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LTD | PUNE | 23 | $647K | Tablet, Capsule | Americas |
| 2 | ALEMBIC PHARMACEUTICALS LTD | GUJARAT | 9 | $152K | Tablet, Capsule | Oceania, Americas |
| 3 | INVENTIA HEALTHCARE LTD | MUMBAI | 6 | $62K | Tablet, Other, Capsule | Asia |
| 4 | TORRENT PHARMACEUTICALS LTD | DARJEELING | 9 | $58K | Tablet | Asia |
| 5 | PIRAMAL PHARMA LTD | DHAR | 1 | $21K | Tablet | Americas |
| 6 | LIVEALTH BIOPHARMA PVT LTD | MUMBAI | 3 | $17K | Tablet | Americas |
| 7 | J B CHEMICALS AND PHARMACEUTICALS LTD | WORLI MUMBAI | 1 | $13K | Tablet | Asia |
| 8 | RONALD PHARMACEUTICALS PVT LTD | VADODARA | 1 | $8K | Tablet | Americas |
| 9 | MODI-MUNDIPHARMA PVT LTD | MODIPURAM | 5 | $6K | Tablet | Asia |
| 10 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 2 | $4K | Gel | Asia |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 3 | $4K | Tablet | Asia |
| 12 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 2 | $4K | Gel | Asia |
| 13 | DOSSMEGT PHARMACEUTICALS PVT LTD | MULUND WEST | 1 | $3K | Tablet | Americas |
| 14 | TROIKAA PHARMACEUTICALS LTD | SANAND AHMEDABAD | 1 | $2K | Gel | Africa |
| 15 | ZEAL PHARMA | NEW KOSAD ROAD AMROLI | 4 | $2K | Gel | Asia |
| 16 | MILTON LIFECARE PVT LTD | MUMBAI | 1 | $2K | Gel | Asia |
| 17 | KERK | DELHI | 1 | $1K | Gel | Asia |
| 18 | MEDEX PHARMACEUTICALS | KULASEKHARAM POST | 6 | $917.16 | Tablet, Injection | Asia |
| 19 | GLENMARK PHARMACEUTICALS LTD | GOA | 1 | $895.09 | Tablet | Europe |
| 20 | ELITE MEDICOS | OPP. QUTAB AUTOMOBILES | 3 | $813.61 | Tablet | Oceania |
| 21 | RUTVA MEDICARE | SURAT | 10 | $554.87 | Tablet, Gel | Africa, Asia |
| 22 | DECINA PHARMA PVT LTD | PUNE | 1 | $406.40 | Tablet | Asia |
| 23 | DOSHI MEDICARE PVT LTD | MUMBAI | 1 | $303.57 | Gel | Asia |
| 24 | DROPS PHARMA PVT LTD | HOSDURG | 2 | $249.48 | Injection | Asia |
| 25 | BAKER & DAVIS PVT LTD | MUMBAI | 5 | $222.64 | Tablet | Asia, Africa |
| 26 | VATS INDUSTRIES PVT LTD | DDA SHED | 1 | $216.16 | Tablet | Asia |
| 27 | HUMANKIND PHARMA | Mumbai | 1 | $215.04 | Gel | Asia |
| 28 | KLV HEALTHCARE PVT LTD | DAHISAR | 2 | $190.00 | Tablet | Africa |
| 29 | DISTINCT IMPEX PVT LTD | MUMBAI | 1 | $173.39 | Tablet | Americas |
| 30 | DERRIC WOOD | SUBHASH PLACE | 11 | $147.27 | Capsule, Tablet | Asia |
| 31 | SARA TRADING CORP | JABALPUR | 3 | $145.39 | Gel | Americas |
| 32 | M.K.PHARMA | BHAWANI MANDI | 1 | $122.90 | Gel | Asia |
| 33 | LAWRENCE WALTER | DELHI | 6 | $115.83 | Capsule | Asia |
| 34 | MUNANI PHARMACEUTICALS PVT LTD | MUMBAI | 1 | $84.74 | Gel | Asia |
| 35 | ONCO INDIA INTERNATIONAL | SURAT | 1 | $75.88 | Gel | Americas |
| 36 | NALIINI.R.EXPORT PVT LTD | CHENNAI | 1 | $48.35 | Tablet | Africa |
| 37 | MEDICOS LIFESCIENCES | AHMEDABAD | 2 | $40.06 | Tablet | Africa |
| 38 | NU HOSPITALS PVT LTD | BENGALURU | 6 | $39.39 | Tablet | Asia |
| 39 | MC PHARMA DISTRIBUTORS | CHENNAI | 7 | $30.27 | Tablet | Asia |
| 40 | MOVID IMPEX | MUMBAI | 2 | $21.58 | Capsule | Asia |
| 41 | SOINS IMPEX | PHASE-1 | 1 | $20.91 | Ointment | Africa |
| 42 | KALINDI OVERSEAS | MUMBAI | 1 | $15.22 | Gel | Americas |
| 43 | NAMAN GLOBAL IMPEX PVT LTD | MUMBAI | 1 | $14.81 | Capsule | Americas |
| 44 | MEDICARE PHARMA | CHENNAI | 1 | $14.27 | Tablet | Asia |
| 45 | BIOLOG PHARMA PVT LTD | AHMEDABAD | 1 | $11.55 | Tablet | Oceania |
| 46 | VEA IMPEX (I) PVT LTD | MUMBAI | 3 | $8.61 | Capsule, Injection, Tablet | Africa, Europe |
| 47 | AARK PHARMACEUTICALS | NEW DELHI | 1 | $0.940 | Vial | Europe |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 30 global diltiazem importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian diltiazem in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MARCAN PHARMACEUTICALS INC | Canada | 23 | $647K | EMCURE PHARMACEUTICA… | Tablet, Capsule |
| 2 | J. KNIPPER & COMPANY | United States | 8 | $141K | ALEMBIC PHARMACEUTIC… | Tablet, Capsule |
| 3 | PHARMACHEM PVT LTD | Nepal | 9 | $58K | TORRENT PHARMACEUTIC… | Tablet |
| 4 | TO HATTON NATIONAL BANK PLC | Sri Lanka | 4 | $53K | INVENTIA HEALTHCARE … | Tablet, Other |
| 5 | TEVA PHARMACEUTICALS USA INC | United States | 1 | $21K | PIRAMAL PHARMA LTD | Tablet |
| 6 | GEORGE STEUART HEALTH PVT LTD | Sri Lanka | 1 | $13K | J B CHEMICALS AND PH… | Tablet |
| 7 | ARROW PHARMACEUTICALS LTD | Australia | 1 | $12K | ALEMBIC PHARMACEUTIC… | Tablet |
| 8 | TO SAMPATH BANK PLC | Sri Lanka | 2 | $9K | INVENTIA HEALTHCARE … | Capsule |
| 9 | UTL PHARMACY PVT LTD | Nepal | 5 | $6K | MODI-MUNDIPHARMA PVT… | Tablet |
| 10 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 3 | $4K | SEATRACK INTERNATION… | Gel |
| 11 | LIANA TRADE CONCERN PVT LTD | Nepal | 2 | $3K | SUN PHARMACEUTICAL I… | Tablet |
| 12 | CASA DE REPRESENTACION MARQUEZ Y K | Venezuela | 1 | $3K | DOSSMEGT PHARMACEUTI… | Tablet |
| 13 | GULF PHARMACIES W.L.L | Bahrain | 1 | $2K | MILTON LIFECARE PVT … | Gel |
| 14 | MUBARAK HASHIMI LTD | Afghanistan | 1 | $1K | KERK | Gel |
| 15 | GLENMARK PHARMACEUTICALS S.R.O | Czech Republic | 1 | $895.09 | GLENMARK PHARMACEUTI… | Tablet |
| 16 | BEST INTERNATIONAL FZE | United Arab Emirates | 5 | $757.44 | MEDEX PHARMACEUTICALS | Tablet, Injection |
| 17 | JDS CO LTD | Myanmar | 1 | $705.26 | SUN PHARMACEUTICAL I… | Tablet |
| 18 | IMPERIAL PHOENIX CO LTD | Myanmar | 1 | $406.40 | DECINA PHARMA PVT LTD | Tablet |
| 19 | EMIRATES POST COMPANY | United Arab Emirates | 17 | $263.10 | DERRIC WOOD | Capsule, Tablet |
| 20 | FREIGHTER MADE LOGISTICS LTD | Ghana | 2 | $189.78 | BAKER & DAVIS PVT LTD | Tablet |
| 21 | LLC SHIFOI SONI | Tajikistan | 1 | $122.90 | M.K.PHARMA | Gel |
| 22 | CARIMED TRADING | Saint Lucia | 2 | $72.95 | SARA TRADING CORP | Gel |
| 23 | CENTRAL POINT PHARMACY | Seychelles | 1 | $48.35 | NALIINI.R.EXPORT PVT… | Tablet |
| 24 | TREE TOP HEALTH PVT LTD | Maldives | 8 | $44.54 | MC PHARMA DISTRIBUTORS | Tablet |
| 25 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 2 | $40.06 | MEDICOS LIFESCIENCES | Tablet |
| 26 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | 3 | $35.67 | NU HOSPITALS PVT LTD | Tablet |
| 27 | ARROW TRADING FZE | United Arab Emirates | 2 | $21.87 | BAKER & DAVIS PVT LTD | Tablet |
| 28 | EMIRATES POST GROUP | United Arab Emirates | 2 | $21.58 | MOVID IMPEX | Capsule |
| 29 | THE PHARMACIST | Cayman Islands | 1 | $15.22 | KALINDI OVERSEAS | Gel |
| 30 | STATE TRADING ORGANIZATION PLC | Maldives | 3 | $3.72 | NU HOSPITALS PVT LTD | Tablet |
This report covers 157 2025-Q4 Diltiazem shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/diltiazem
Talk to our trade analyst
Need a custom diltiazem report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/diltiazem
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Diltiazem product page
Live data, supplier directory, price trends, and trade route analysis